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The patient is a 69-year-old male. His chief complaint was chest pain. Because imaging studies
suggested pleural mesothelioma associated with multiple bone metastases, right pleural tumor resection was
performed. Pathological diagnosis was metastatic pleural tumor, and renal cell carcinoma (RCC) was
suspected as its origin. Dynamic computed tomography showed a small tumor in the right kidney. The
tumor was 15 mm in diameter and consistent with RCC. Laparoscopic radical nephrectomy was performed
for the right kidney. Pathological diagnosis was RCC, clear cell carcinoma with sarcomatoid component,
T1aN0M1, stage IV. Sorafenib therapy was started 46 days after the operation as a systemic therapy, and
stable disease has been maintained. Generally, small RCC is assumed to have a good prognosis.
However, a small percentage of patients with small RCC have distant metastasis at the time of diagnosis, and
the prognosis is reported to be poor. We report this case, and a review of the literature.
(Hinyokika Kiyo 57 : 497-500, 2011)





















Fig. 1. Chest X-ray showed pleural effusion and






画像所見 (Fig. 2) : Dynamic CT にて右腎中極に動
脈相で濃染し，平衡相で washout される 1.5 cm の腫
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Fig. 2. Dynamic CT of the kidney (a : plain, b : early phase, c : delayed phase) and bone scintigraphy (d).
泌57,09,05-3a
泌57,09,05-3b 泌57,09,05-3c
Fig. 3. Pathological findings (a : right kidney, b : right kidney, H-E, ×200, c : pleural metastasis,
HE ×200).








入院後経過（当科) : 右腎病変は 1.5 cm と小径で
あったが，部分切除術が困難な central location であっ
たため，2010年 2月，鏡視下右腎摘術を施行した．
病理組織学的所見 (Fig. 3a，b) : RCC，clear cell
carcinoma with sarcomatoid component，G2＞ 3＞ 1，
INFα，v (−），pT1aN0M1
腎病変 (Fig. 3b) と胸膜病変 (Fig. 3c) の病理像を比





日目より sorafenib 800 mg/day 内服を開始した． 8，
16週目の評価 CT では stable disease であった．有害事
象として，grade 3 の肝機能障害が出現し一時休薬し
たが，肝機能改善後に 400 mg/day に減量して投与再































Clear cell ＋ 癌あり生存 17
2 59/M 検診 肺 3.0 Clear cell ＋ 癌あり生存 19
3 73/M MDS*follow







骨 2.7 Clear cell ＋ 癌死 68






瘤 骨 2.5 根治的腎摘術
不明
Clear cell ＋ 癌あり生存 27
7 70/M 右腕痛 骨 3.0 塞栓術 Clear cell，sarcomatoidcomponent
不明
癌死 5









10 48/M 背部痛 骨 1.5 根治的腎摘術 Clear cell，sarcomatoidcomponent 癌死 27
11 ― 右大腿痛 骨 2.5 根治的腎摘術 IFN Clear cell 癌死 27
12 ― 検診 肺 2.0 根治的腎摘術 IFN Clear cell 癌あり生存 ―


























小径腎細胞癌のサイズは，一般的に径 3.0 cm 以下
とされている6,8,9)．石岡らは，径 4.0 cm 以下の腫瘍
を対象としているが，「遠隔転移に視点をおいた場合
のカットオフポイントは 3.0 cm にすべき」と考察し
ており7)，本論文では 3.0 cm 以下を対象とした．ま
た，径 3.0 cm 以下の腫瘍に比べて径 3.1∼4.0 cm の
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